Results 81 to 90 of about 194 (96)
Some of the next articles are maybe not open access.
Annals of Tropical Medicine & Parasitology, 2004
Samples of peripheral blood were collected once from non-smoking women who were healthy (controls) and twice (immediately before and immediately after 7 days of treatment with metronidazole at 500 mg/day) from non-smoking women infected with Trichomonas vaginalis.
M A, Carballo, A M, Palermo, M D, Mudry
openaire +2 more sources
Samples of peripheral blood were collected once from non-smoking women who were healthy (controls) and twice (immediately before and immediately after 7 days of treatment with metronidazole at 500 mg/day) from non-smoking women infected with Trichomonas vaginalis.
M A, Carballo, A M, Palermo, M D, Mudry
openaire +2 more sources
Evaluation of in vitro Toxicogenetic Models for Hepatotoxicity
2010Numerous studies support the fact that a genetically diverse mouse population may be useful as an animal model to understand and predict toxicity in humans. We hypothesized that cultures of hepatocytes obtained from a large panel of inbred mouse strains can produce data indicative of inter-individual differences in in vivo responses to hepato-toxicants.
openaire +1 more source
[Toxicogenetic effects of azo- and arylmethane dyes].
Genetika, 1991The haploid strain 15B-II4 of Saccharomyces cerevisiae was used to study in an acute experiment the toxic and mutagenic effects of arylmethane dyes Victory Blue (C.I. 44040), Methyl Violet (C.I. 42535), Brilliant Green (C.I. 42040) and cancerogenic aminoazo dye Chrysoidine (C.I. 11270).
T A, Zimina, V V, Pavlenko
openaire +1 more source
[Toxicogenetics and toxicogenomics. Relevance and application in occupational health].
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2006Xenobiotic metabolising enzymes modify most organic compounds into water soluble compounds. Sequence variations of these enzymes can lead to significant interindividual differences in the metabolism of xenobiotics. This review covers important sequence variations of phase I (cytochrome P450) and phase II (glutathion S-transferases, N-acetyltransferases,
openaire +1 more source
Genetic Risk Prediction: Individualized Variability in Susceptibility to Toxicants
Annual Review of Pharmacology and Toxicology, 2013Daniel W. Nebert, Elliot S Vesell
exaly

